Patents by Inventor Venkatesh Naini

Venkatesh Naini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220241307
    Abstract: The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
    Type: Application
    Filed: February 4, 2022
    Publication date: August 4, 2022
    Inventors: Beatriz Fernandes, João Henriques, Eunice Costa, Venkatesh Naini
  • Publication number: 20220142964
    Abstract: The present invention contemplates a high dose finished pharmaceutical dosage form comprising colestipol hydrochloride in its commercially available form (i.e., beads) without the need for further milling. A manufacturing process used to manufacture the instant high dose finished pharmaceutical dosage form comprising colestipol hydrochloride, which monitors moisture content throughout the granulation process, is also disclosed herein.
    Type: Application
    Filed: November 10, 2020
    Publication date: May 12, 2022
    Applicant: Edenbridge Pharmaceuticals, LLC
    Inventors: Venkatesh Naini, Velayutham Kanniyappan
  • Publication number: 20100015239
    Abstract: The present invention relates to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising delayed-release lansoprazole, processes for preparing the dosage forms, and methods for treating one or more conditions with the dosage forms.
    Type: Application
    Filed: July 16, 2009
    Publication date: January 21, 2010
    Inventors: Salah U. AHMED, Sudhir R. Gorukanti, Venkatesh Naini
  • Publication number: 20060002989
    Abstract: The present invention is directed to pharmaceutical compositions comprising sumatriptan succinate and sodium caprate for increased absorption of sumatriptan succinate across biological membranes. The invention is also directed to methods of making the pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: June 10, 2005
    Publication date: January 5, 2006
    Inventors: Salah Ahmed, Lianli Li, Venkatesh Naini